Transaction expected to close in next 6 weeks
Sequent Scientific and Lyka Labs announced that Alivira Animal Health, a subsidiary of Sequent, and Lyka Exports, a subsidiary of Lyka Labs, have entered into a definitive agreement under which Alivira will acquire the Animal Healthcare Business of Lyka on a 'going concern' basis.The transaction is expected to close in next 6 weeks subject to customary closing conditions including shareholder's approval of Lyka.
Powered by Capital Market - Live News
